Sherbrooke Park Advisers LLC Novavax Inc Transaction History
Sherbrooke Park Advisers LLC
- $230 Billion
- Q2 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Novavax Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 20,680 shares of NVAX stock, worth $174,332. This represents 0.06% of its overall portfolio holdings.
Number of Shares
20,680
Previous 12,243
68.91%
Holding current value
$174,332
Previous $78.5 Million
66.01%
% of portfolio
0.06%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding NVAX
# of Institutions
308Shares Held
94.2MCall Options Held
6.11MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$130 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$99.9 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$97 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$57.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$33.2 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $659M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...